FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HU, V. W.
Right arrow Articles by HA, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HU, V. W.
Right arrow Articles by HA, L.
(The FASEB Journal. 2001;15:1562-1568.)
© 2001 FASEB

Metabolic radiolabeling: experimental tool or Trojan horse? 35S-Methionine induces DNA fragmentation and p53-dependent ROS production

VALERIE W. HU1, DANIEL S. HEIKKA, PAUL B. DIEFFENBACH and LINAN HA

Department of Biochemistry and Molecular Biology, The George Washington University, School of Medicine and Health Sciences, Washington, D.C. 20037, USA

1Correspondence: Department of Biochemistry and Molecular Biology, The George Washington University, School of Medicine and Health Sciences, 2300 Eye St., N.W., Ross Hall 526, Washington, D.C. 20037, USA. E-mail: bcmvwh{at}gwumc.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Despite the general assumption that widely used radiolabeled metabolites such as [35S]methionine and 3H-thymidine do not adversely affect or perturb cell function, we and others have shown that such low-energy ß-emitters can cause cell cycle arrest and apoptosis of proliferating cells. The goal of the present study was to elucidate the targets and mechanisms of [35S]methionine-induced cellular toxicity. Comet analyses (single-cell electrophoresis) demonstrated dose-dependent DNA fragmentation in rabbit smooth muscle cells within a time frame (1–4 h) well within that of most radiolabeling protocols, whereas fluorescence analyses using a peroxide/hydroperoxide-sensitive dye revealed production of reactive oxygen species (ROS). Although ROS generation was inhibitable by antioxidants, DNA fragmentation was not inhibited and was in fact observed even under hypoxic conditions, suggesting that ß-radiation-induced DNA damage can occur independently of ROS formation. Studies with p53+/+ and p53-/- human colorectal carcinoma cells further demonstrated the dissociation of early DNA damage from ROS formation in that both cell types exhibited DNA fragmentation in response to radiolabeling whereas only the p53+/+ cells exhibited significant increases in ROS formation, which occurred well after significant DNA damage was observed. These findings demonstrate that metabolically incorporated low-energy ß-emitters such as [35S]methionine and 3H-thymidine can induce DNA damage, thereby initiating cellular responses leading to cell cycle arrest or apoptosis. The results of this study require a reevaluation using low-energy ß-emitters to follow not only experimental protocols in vivo processes, but also acceptable exposure levels of these genotoxic compounds in the workplace and environment.—Hu, V. W., Heikka, D. S., Dieffenbach, P. B., Ha, L. Metabolic radiolabeling: experimental tool or Trojan horse? 35S-Methionine induces DNA fragmentation and p53-dependent ROS production.


Key Words: metabolic labeling • radioisotopes • DNA fragmentation • reactive oxygen species • p53


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
METABOLIC LABELING WITH [35S]methionine is a technique commonly used to follow the biosynthesis, trafficking, and/or degradation of proteins in vivo (1) . Because cells often appear viable immediately after labeling or after short-term pulse-chase experiments, it has been assumed that the radioisotope is innocuous at the levels typically used. However, several recent studies, including ours, have shown that cell-incorporated low-energy ß-emitters such as [35S]methionine and 3H-thymidine can cause cell cycle arrest and apoptosis (2 3 4 5 6) . Cell cycle arrest is most obvious in cultures of radiolabeled synchronized cells that fail to divide within their normal division cycle and has been attributed, in at least two cases, to increases in the level of p53 (3 , 4) , a major cell cycle checkpoint regulator that serves as a molecular sensor for DNA damage (7) . However, there is little substantiation of the occurrence of DNA damage by these low-energy ß-emitters at the doses used in metabolic labeling experiments, with the exception of two studies in which hemopoietic cells were labeled with 3H-thymidine for 24 or more hours (2 , 6) .

Here, we report that exposure of cells to [35S]methionine induces not only DNA damage, but also generates a significant amount of reactive oxygen species (ROS), at least in the cell types studied. Furthermore, these two events can be dissociated temporally as well as differentiated by their respective response to inhibitors of ROS and their relative dependence on p53. Collectively, these studies establish a molecular mechanism for the initiation of cell cycle arrest and/or apoptosis by low-energy ß-emitting radioisotopes. Moreover, our finding that radiolabeling also induces ROS production mandates further study to evaluate the effect of this oxidative stress on cell metabolism and signal transduction.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Cells and culture conditions
Rabbit smooth muscle cells (RSMC) were kindly provided by Dr. Gene Liau (Novartis Pharmaceuticals, Summit, NJ) and were cultured in M199 medium supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Atlanta, GA), 2 mM glutamine, antibiotic/antimycotic solution to final concentrations of 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, and geneticin at 250 µg/ml. The A6 line used here has been described (5) . The NIH 3T3 murine fibroblasts were obtained from Dr. Patricia Berg (The George Washington University Medical Center) and were cultured in Dulbecco’s minimum essential medium (DMEM) supplemented with 10% FBS. The p53+/+ and p53-/- human colorectal carcinoma cell lines were generously provided by Dr. Bert Vogelstein (Johns Hopkins University School of Medicine and the Howard Hughes Medical Institute) and were cultured in McCoy’s 5A medium with 10% FBS and antibiotic/antimycotic solution at the concentrations stated above. All media and buffers were purchased from Fisher Scientific (Pittsburgh, PA).

Radiolabeling protocol
Cells in methionine-free DMEM (DMEM-) supplemented with 10% dialyzed FBS and 2 mM glutamine were incubated with 35S-Trans label (spec. act. >1000 mCi/mM; ICN Radiochemicals, Costa Mesa, CA) at different doses and for various periods. In some experiments, a postlabeling incubation in normal medium followed washout of the radiolabel. Control (mock-labeled) cells were incubated with equivalent volumes of matching carrier buffer (50 mM L-lysine, 10 mM beta-mercaptoethanol, pH 7.4) obtained from ICN. Positive controls for the Comet assay consisted of cells treated with 100 µM peroxide for 20 min at 4°C. To evaluate the role of oxygen-derived ROS in DNA fragmentation, cells were subjected to hypoxic conditions before and during the 1.5 h labeling period before Comet analysis. Cells cultured in screw cap flasks were preequilibrated under nitrogen in supplemented DMEM- medium buffered with 25 mM HEPES at pH 7.2–7.4 for 30 min before addition of the radiolabel or carrier buffer. Hypoxia was maintained during incubation with 35S-Trans label by flushing the flasks with nitrogen and capping the flasks tightly. Harvested cells were also flushed with nitrogen to maintain a hypoxic atmosphere prior to preparation of the Comet slides. In one experiment described here, cells were labeled with 3H-thymidine (spec. act. 77 Ci/mmol; ICN Radiochemicals) for 2 h, washed, incubated in normal medium for 1 h, and evaluated for DNA fragmentation by the Comet assay. In other studies, 5 mM allopurinol (Sigma, St. Louis, Mo.), a xanthine oxidase inhibitor, was included in the medium during the labeling as well as postlabeling periods before harvesting of cells for Comet analyses or before ROS assays.

Comet assay for DNA fragmentation
The Comet assay involves single-cell electrophoresis in agarose as first described by Ostling and Johanson (8) . Cells were incubated with radiolabel or carrier buffer (for mock-labeled controls) for various periods of time and at different doses of radiolabel and analyzed for DNA fragmentation using a CometAssayTM kit (Trevigen, Gaithersburg, MD), following procedures outlined by Trevigen for the neutral Comet assay. Under neutral conditions, the Comet assay will detect primarily double-stranded DNA breaks. In brief, radiolabeled and control cells were harvested with trypsin-EDTA solution, washed, and suspended in low melting agarose at ~ 105 cells/ml. The agarose was applied to CometSlidesTM and allowed to set at 4°C. After lysis of the agarose-embedded cells in Lysis Solution (2.5 M NaCl, 100 mM EDTA, pH 10, 10 mM Tris base, 1% sodium lauryl sarcosinate, 0.01% Triton X-100), the slides were placed in a Bio-Rad (Hercules, CA) submarine gel electrophoresis unit and electrophoresed in TBE, pH 8 (0.089 M Tris/0.089 M boric acid/0.003 M EDTA) at 1 V/cm for 30 min. The samples were then fixed in MeOH and EtOH (5 min. each) at -20°C and dried overnight before staining with SyBr Green to visualize cellular DNA.

Fluorescence microscopy and laser scanning cytometry
SyBr Green-stained samples were examined by fluorescence microscopy using an Olympus IX70-inverted system microscope equipped with an IX-FLA inverted reflected light fluorescence observation attachment. Pictures were recorded with an Olympus PM-20 photomicrographic system using a 20x objective. For quantitation of the relative amount of DNA fragmentation in different samples, the stained slides were scanned with a Meridian ACAS570 Interactive Laser Cytometer at an excitation wavelength of 488 nm using laser power of 60 mW and scan strength of 10%, with a 10% neutral density filter. The pseudocolor fluorescence images (see Fig. 1B ) were analyzed using the Cell Image program to circumscribe the ‘head’ and ‘tail’ regions of each Comet and the integrated (total) fluorescence values of each defined area were recorded. The ratio of tail/head fluorescence was used as a relative measure of DNA fragmentation for each sample. An average of 25 individual Comets were scored per sample.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Dose dependence of [35S]methionine-induced DNA fragmentation. A) Fluorescence microscopic images of Comet analyses of cells labeled with [35S]methionine at 0, 1, 10, and 100 µCi/ml. A peroxide-treated positive control is also shown for comparison. DNA is visualized by staining with SyBr Green. B) Pseudocolor fluorescence image of SyBr Green-stained DNA Comets showing separately outlined ‘head’ and ‘tail’ regions for quantitative analysis. The image was obtained by laser scanning cytometry as described in Materials and Methods. Relative fluorescence intensity is indicated by the color scale shown on the right. C, D) Extent of DNA fragmentation at 2 h (C) and 24 h (D) after radiolabeling as a function of dose of [35S]methionine. The ratio of tail/head fluorescence was determined by image analysis of DNA Comets as described in Materials and Methods. The results show the mean fluorescence ratio (±SE) for at least 25 Comets per sample. *P < 0.01; ***P < 0.0001

Assay for ROS
The fluorogenic, peroxide-sensitive compound 5(6)-chloromethyl-2',7'-dichlorodihydrofluorescin (CM-H2DCF) was used to detect the presence of ROS in living cells in a manner described for the parent compound, 2',7'-dichlorofluorescin (9 , 10) . Cells were first radiolabeled for 2 h with 35S-Trans label, washed, and incubated for varying periods in normal cold medium before staining with a cell-permeable diacetate (DA) form of the dye CM-H2DCFDA (Molecular Probes, Eugene, OR). After entry into the cell and cleavage of the diacetate group by intracellular esterases, this dye becomes fluorescent only after oxidation by peroxide/hydroperoxides to chloromethyldichlorofluorescein (CM-DCF). Laser scanning cytometry using the ACAS570 interactive laser cytometer was again used to quantitate and analyze cell-associated fluorescence. Because of the enlargement of radiolabeled cells over a 24 h period, average fluorescence (integrated fluorescence/number of pixels in area defining each respective cell) was recorded as it was found to be independent of cell size, whereas integrated fluorescence was size dependent (data not shown). At least 100 cells were analyzed per sample. For some studies, cells were incubated with 5 mM allopurinol during and after the labeling period, before staining the cells with CM-H2DCFDA for the ROS assay.

Statistical analyses
All Comet data are expressed as means ± SE. The Student’s unpaired t test was used to determine statistical significance of the difference between labeled samples vs. mock-labeled controls.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Radiolabeling with [35S]methionine causes dose-dependent DNA fragmentation
Although previous studies have shown that metabolic radiolabeling with low-energy ß-emitting radioisotopes can induce cell cycle arrest and apoptosis (2 3 4 5 6) , the initiating mechanism(s) for these effects is(are) unknown. Inasmuch as DNA is a prime target for ionizing radiation (e.g., {gamma}- or X-rays) (11 , 12) , we investigated the effects of cellular incorporation of [35S]methionine on DNA integrity in radiolabeled cells using Comet analyses. Rabbit smooth muscle cells were labeled for 2 h with [35S]methionine at 1, 10 and 100 µCi/ml and analyzed by Comet assay for DNA fragmentation 2 h after the label was washed out and the cells returned to complete medium. As shown in Fig. 1A , DNA fragmentation was indicated by the production of ‘tails’ in the radiolabeled samples, which were longer and thicker with increasing dose. Laser scanning cytometry (LSC) was used to quantitate the relative amount of DNA fragmentation at the different doses as described in Materials and Methods. Figure 1B shows a representative pseudocolor fluorescence image of Comets obtained by LSC; Fig. 1C shows quantitation of tail-to-head ratio as a function of labeling dose. As shown, the degree of DNA fragmentation is directly related to the dose of radiolabel. At 24 h after the labeling period, there is still evidence of DNA fragmentation, although the degree of fragmentation is attenuated relative to that observed 2 h after washout of the label, especially at the lower doses (Fig. 1D ). This latter finding suggests there is some repair of double-stranded DNA breaks in cells exposed to [35S]methionine at 1 and 10 µCi/ml, but relatively little repair at 100 µCi/ml, which is the dose of 35S-label most frequently used in protein labeling protocols (1) . Nevertheless, our previous studies demonstrated that even at 0.1 µCi 35S-label/ml, colony formation was still significantly inhibited in this cell type (5) , suggesting that genotoxic effects of cell-incorporated 35S are still manifested at very low doses despite repair activity. These combined findings therefore call for additional studies to determine whether there is a threshold dose of low-energy internal ß-emitters that results in genotoxicity or sublethal genetic mutations and for reevaluation of safety limits regarding occupational hazards and radioactive waste disposal methods.

Time dependence of DNA fragmentation
To determine the minimum labeling period required for the manifestation of DNA damage, cells were labeled for 0.5, 1, 1.5, and 2 h in [35S]methionine at 100 µCi/ml and analyzed for DNA fragmentation immediately after the respective labeling periods. The results in Fig. 2 show that DNA fragmentation is observed as early as 1 h after the radiolabel is added to the cell culture and increases with increasing time of incubation up to 2 h. These results suggest that a significant amount of DNA damage occurs even before most radiolabeling protocols are completed.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 2. Time dependence of DNA fragmentation as represented by the ratio of tail/head fluorescence (±SE) of DNA Comets of cells labeled with [35S]methionine at 100 µCi/ml for different periods of time. **P < 0.001; ***P < 0.0001

Radiolabel-induced DNA fragmentation is independent of cell type
Several different cell lines were examined for DNA fragmentation in response to metabolic labeling with [35S]methionine. Figure 3 shows that all cell lines tested, including a standard cell model, the 3T3 murine fibroblast, and both p53-positive and p53-negative human colorectal carcinoma cell lines, exhibited significant DNA fragmentation 2 h after a 2 h labeling period. Thus, RSMC cells are not unique in their response to this form of low-energy ß-radiation, suggesting that DNA fragmentation is a common phenomenon associated with metabolic radiolabeling.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 3. Radioisotope-induced DNA fragmentation is independent of cell type. Ratio of tail/head fluorescence (±SE) for samples of both p53+/+ and p53-/- human colorectal carcinoma cells as well as 3T3 murine fibroblasts, each labeled for 2 h with [35S]methionine before washout of the label and a further 2 h incubation in normal medium before Comet analysis. ***P < 0.0001

Tritiated thymidine also induces DNA fragmentation
We also evaluated the potential of another commonly used low-energy ß-emitter, 3H-thymidine, to cause DNA fragmentation. As shown in Fig. 4 , dose-dependent DNA damage was observed as early as 1 h after a 2 h incubation with 3H-thymidine at 2, 20, and 100 µCi/ml. These results are consistent with those previously reported (2 , 6) , but demonstrate a much earlier time point for manifestation of DNA damage by this very low-energy emitter (average beta energy=0.006 MeV).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 4. Tritiated thymidine also induces dose-dependent DNA fragmentation. Ratio of tail/head fluorescence (±SE) of DNA Comets of cells labeled with 3H-thymidine at 0, 2, 20, and 100 µCi/ml for 2 h before washout of the radiolabel and further incubation in normal medium for 1 h preceding Comet analysis. *P < 0.01; ***P < 0.0001

Radiolabeling with 35S-methionine induces ROS formation
Because ionizing radiation is usually associated with the formation of ROS under aerobic conditions, we monitored the formation of ROS using a peroxide-sensitive fluorescent dye, CM-H2DCF. Cells were radiolabeled with [35S]methionine for 2 h, then washed and incubated in complete medium for 2 h before the ROS assay. Cells were loaded with the membrane-permeable form of the dye (CM-H2DCFDA) and analyzed by laser scanning cytometry to detect the formation of intracellular peroxides as indicated by increased dye fluorescence. In contrast to mock-labeled cells, the radiolabeled RSMC exhibited significantly higher levels of fluorescence, as revealed by the fluorescence distribution profiles shown in Fig. 5A , B . Furthermore, the observed increase in fluorescence could be reduced almost to control levels by treatment of radiolabeled cells with the antioxidant allopurinol (Fig. 5C ). A similar inhibition of ROS was obtained with exogenous catalase at 1000 U/ml during the labeling and postlabeling incubation periods (data not shown). These results implicated ROS as a possible mediator of DNA damage. Thus, the effects of antioxidants and hypoxia on DNA fragmentation were investigated.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 5. ROS production in radiolabeled cells is inhibited by antioxidants. Fluorescence distribution profiles of control (B, D) and labeled (A, C) RSMC in the absence (A, B) or presence (C, D) of allopurinol (5 mM). Cells were labeled with [35S]methionine at 100 µCi/ml for 2 h, followed by removal of unincorporated radiolabel and a further incubation in normal medium with allopurinol for 2 h before assay for ROS. The data represent fluorescence quantitation of an average of 153 cells/sample and are representative of 3 separate experiments examining allopurinol-inhibition of ROS production.

ROS inhibitors and hypoxia do not attenuate DNA fragmentation
Even though [35S]methionine could induce antioxidant-inhibitable elevation of ROS in RSMC (Fig. 6 ), these same antioxidants were not able to inhibit DNA fragmentation, as detected by the Comet assay (data not shown). Because the specific antioxidants used may not have eliminated all potentially damaging forms of ROS, the radiolabeling experiments were also carried out under nitrogen to induce hypoxia. As shown in Fig. 6 , DNA fragmentation was observed even under hypoxic conditions 1.5 h after addition of label. In contrast, the earliest detectable increase in CM-DCF fluorescence in RSMC occurred at 2 h postlabeling. Taken together, these results suggest that either ROS was present, but at a level undetectable by the CM-DCF fluorescence assay at the earlier time points at which DNA fragmentation was clearly observable, or that ROS is not a necessary initiator of [35S]methionine-induced DNA damage. The results with hypoxic cells would support the latter case.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 6. Radiolabel induces DNA fragmentation under hypoxic conditions. Comet analyses of [35S]methionine-labeled cells were performed 1.5 h after the label was introduced. The results show the ratio of tail/head fluorescence (±SE) of DNA Comets of control (open bars) and labeled (stippled bars) cells under both normoxic and hypoxic conditions. ***P < 0.0001

p53 is associated with ROS production but is not necessary for DNA fragmentation
Because p53 has been implicated in the formation of ROS through transcriptional induction of redox-related genes (13) , we examined p53+/+ and p53-/- cells for [35S]methionine-induced ROS formation and DNA fragmentation. Figure 7 shows that ROS was detectable by CM-DCF fluorescence only in the radiolabeled p53+/+ cells 24 h after labeling. Earlier time points (e.g., 2 h after washout of the radiolabel) showed no significant rise in ROS levels in either p53+/+ or p53-/- cells, despite clear evidence for DNA fragmentation 2 h after labeling for both these cell types (see Fig. 3 ). Thus, despite an association between functional p53 expression and ROS formation, there was a p53 as well as temporal dissociation between ROS production and DNA fragmentation. These results further imply that at least initial DNA fragmentation by low-energy internal ß-radiation is independent of oxygen-derived ROS.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 7. p53 is associated with ROS production. p53+/+ and p53-/- human colorectal carcinoma cells were labeled for 2 h with [35S]methionine at 100 µCi/ml. The results show fluorescence distribution profiles for control and labeled cells incubated for 24 h in normal medium after washout of the radiolabel.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Our studies have shown that both [35S]methionine and 3H-thymidine can induce significant DNA fragmentation within the time frame (e.g., 1–4 h) of many metabolic labeling experiments. These results thus identify DNA as a target for the low-energy ß-radiation given off by these widely used radioactive metabolites. These studies also provide a molecular explanation for the rise in p53 protein level that has been associated with radiolabeling procedures involving low-energy ß-emitting radioisotopes and the downstream effects of p53 activation, including cell cycle arrest and apoptosis (2 3 4 5 6) .

Aside from DNA fragmentation, metabolic labeling with [35S]methionine was associated with a rise in ROS as detected by the peroxide-sensitive fluorescent dye, CM-H2DCF. However, the ROS detected cannot be responsible for the radioisotope-induced DNA damage observed, because DNA fragmentation precedes ROS formation and could not be inhibited by antioxidants, which were nevertheless able to inhibit the rise of ROS in radiolabeled cells. To rule out the possibility that other forms of oxygen-derived ROS (e.g., superoxide) were responsible for DNA fragmentation, the radiolabeling procedure was carried out under nitrogen. The results in Fig. 6 show that DNA fragmentation was still significant under hypoxic conditions. Although the reduced level of fragmentation in hypoxic cells (~68% of normoxic level) may be regarded as evidence for partial ROS contribution to DNA damage; it can also be explained by a measured 50–66% reduction in uptake of [35S]methionine during hypoxia.

Another novel and significant finding of these studies is that functional p53 expression correlates with radiolabel-induced ROS but not DNA damage. This observation not only further dissociates ROS from early induction of DNA fragmentation, but also is consistent with a model for p53-induced apoptosis proposed by Polyak et al. (13) in which functional p53 expression induces p53-inducible genes, which in turn leads to elevation of ROS in cells. The relative time scale of DNA fragmentation and ROS production in our studies appears to be consistent with this scenario; that is, DNA fragmentation, which presumably initiates activation of p53, precedes ROS formation by 1 h or longer. In fact, we observed an increase in p53 protein in RSMC as early as 30 min after the label is added (D. S. Heikka and V. W. Hu, unpublished results), at which time DNA damage is already detectable in some cells by Comet assay. It is also noteworthy that there is a longer lag time between DNA fragmentation and ROS production in the p53+/+ human carcinoma cells, suggesting that the kinetics or mechanism of ROS production in response to internal ß-radiation may be dependent on cell type.

The mechanism of DNA damage induced by the low-energy ß-radiation from [35S]methionine or 3H-thymidine is not known, although free radical production is a common result of ionizing radiation (12) . In an aqueous intracellular environment, the most abundant free radicals are likely to be water and hydroxyl radicals, which in turn may ionize biological molecules, including DNA. We have indeed observed some attenuation of DNA fragmentation in the presence of sulfhydryl compounds (V. W. Hu, unpublished results), suggesting the involvement of free radicals in DNA damage, but the chemical nature of the radicals and the DNA damage remains to be identified. On a broader scope, if ionization by water and hydroxyl radicals is a common mechanism of DNA damage by cell-incorporated radio emitters, then the application of all forms of radiolabels for in vivo labeling or tracking (including 14C-labeled metabolites) would need to be reevaluated in terms of their effect on cell function. In fact, a recent study has shown that metabolic labeling with 32P-orthophosphate also activates p53, inducing p53-dependent growth arrest in human fibroblasts (14) . These results collectively emphasize the need to find and use alternative, nonradioactive tools for the in vivo analysis of cellular activities.

Finally, although oxygen-derived ROS has been excluded as an initiator of the low-energy ß-induced DNA fragmentation, as seen by Comet analyses, its potential contribution to downstream apoptotic events or other adverse cellular responses cannot be overlooked. For example, it is becoming increasingly clear that ROS and free radicals play a substantial role in signal transduction both physiologically and pathologically (15 16 17) . Even if metabolic labeling with low-energy ß-emitters does not always lead to cell cycle arrest, inhibition of cell proliferation, or apoptosis, as we and others have reported (2 3 4 5 6) , it is likely, given our current findings, to alter the redox status of the cell and associated processes. Thus, rather than serving as an experimental tool to track metabolic and signaling activities in vivo, radiolabels may actually be perturbing or undermining the system they were meant to study.


   ACKNOWLEDGMENTS
 
We are grateful to Drs. Susan Ceryak and Allan Goldstein for helpful discussions and careful reading of the manuscript. We also thank Dr. Steven Patierno for providing generous access to his fluorescence microscope and photomicrographic system and Ms. Viola Bello for analyses of Comet data. This work was supported by an NSF-SGER grant for exploratory research and in part by an intramural FREF grant.

Received for publication February 2, 2001. Accepted for publication March 26, 2001.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Pollard, J. W. (1996) Radioisotopic labeling of proteins for polyacrylamide gel electrophoresis. Walker, J. M. eds. The Protein Protocols Handbook Humana Press Totowa, N.J..
  2. Solary, E., Bertrand, R., Jenkins, J., Pommier, Y. (1992) Radiolabeling of DNA can induce its fragmentation in HL-60 human promyelocytic leukemic cells. Exp. Cell Res. 203,495-498[Medline]
  3. Dover, R., Jayaram, Y., Patel, K., Chinery, R. (1994) p53 expression in cultured cells following radioisotope labelling. J. Cell Sci. 107,1181-1184[Abstract]
  4. Yeargin, J., Haas, M. (1995) Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Curr. Biol. 5,423-431[Medline]
  5. Hu, V. W., Heikka, D. S. (2000) Radiolabeling revisited: metabolic labeling with 35S-methionine inhibits cell cycle progression, proliferation, and survival. FASEB J 14,448-454[Abstract/Free Full Text]
  6. Yanokura, M., Takase, K., Yamamoto, K., Teraoka, H. (2000) Cell death and cell-cycle arrest induced by incorporation of [3H]thymidine into human haemopoietic cell lines. Int. J. Radiat. Biol. 76,295-303[Medline]
  7. Lakin, N. D., Jackson, S. P. (1999) Regulation of p53 in response to DNA damage. Oncogene 13,7644-7655
  8. Ostling, O., Johanson, K. J. (1984) Microelectrophoretic study of radiation-induced DNA damage in individual mammalian cells. Biochem. Biophys. Res. Commun. 123,291-298[Medline]
  9. Carter, W. O., Narayanan, P. K., Robinson, J. P. (1994) Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55,253-258[Abstract]
  10. Rothe, G., Valet, G. (1990) Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J. Leukoc. Biol. 47,440-448[Abstract]
  11. Radford, I. R. (1986) Evidence for a general relationship between the induced level of DNA double-strand breakage and cell killing after x-irradiation of mammalian cells. Int. J. Radiat. Biol. 49,611-620
  12. Ward, J. F. (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog. Nucleic Acids Res. Mol. Biol. 35,95-125[Medline]
  13. Polyak, K., Xia, Y., Zweler, J. L., Kinzler, K. W., Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature (London) 389,300-305[Medline]
  14. Bond, J. A., Webley, K., Wyllie, F. S., Jones, C. J., Craig, A., Hupp, T., Wynford-Thomas, D. (1999) p53-dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P-ortho-phosphate in human fibroblasts. Oncogene 18,3788-3792[Medline]
  15. Lander, H. M. (1997) An essential role for free radicals and derived species in signal transduction. FASEB J 11,118-124[Abstract]
  16. Nakamura, H., Nakamura, K., Yodoi, J. (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15,351-369[Medline]
  17. Suzuki, Y. J., Forman, H. J., Sevanian, A. (1997) Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22,269-285[Medline]



This article has been cited by other articles:


Home page
J. Virol.Home page
H. Yuan, M. Kamata, Y.-M. Xie, and I. S. Y. Chen
Increased Levels of Wee-1 Kinase in G2 Are Necessary for Vpr- and Gamma Irradiation-Induced G2 Arrest
J. Virol., August 1, 2004; 78(15): 8183 - 8190.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. F. MARKO, P. B. DIEFFENBACH, G. YAN, S. CERYAK, R. W. HOWELL, T. A. MCCAFFREY, and V. W. HU
Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation
FASEB J, August 1, 2003; 17(11): 1470 - 1486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Schulenberg, R. Aggeler, J. M. Beechem, R. A. Capaldi, and W. F. Patton
Analysis of Steady-state Protein Phosphorylation in Mitochondria Using a Novel Fluorescent Phosphosensor Dye
J. Biol. Chem., July 11, 2003; 278(29): 27251 - 27255.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Roos-Mattjus, K. M. Hopkins, A. J. Oestreich, B. T. Vroman, K. L. Johnson, S. Naylor, H. B. Lieberman, and L. M. Karnitz
Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling
J. Biol. Chem., June 27, 2003; 278(27): 24428 - 24437.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HU, V. W.
Right arrow Articles by HA, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HU, V. W.
Right arrow Articles by HA, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS